Publication | Closed Access

A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi

VaccinationVaccine DevelopmentVaccine TargetPathogenesisImmunologyMicrobiologyInfection ControlStreptococcus Pneumoniae StrainsPolyvalent VaccineMedicineVaccine ResearchVaccine DesignPspa Families 1Bivalent Conjugate Vaccine